Table 2 Anti-malarial seropositivity and seroconversion rates for participants in Chabahar city and surrounding villages, south-eastern Iran
Prevalence, % (n/N) | ||||||
|---|---|---|---|---|---|---|
City | Village | |||||
P. falciparum | P. vivax | P.f/P.v | P. falciparum | P. vivax | P.f/P.v | |
1 to 5 | 2 (4/174) | 4 (7/174) | 1 (1/174) | 0 (0/159) | 5 (8/159) | 0 (0/159) |
6 to 15 | 3 (5/191) | 7 (14/191) | 1 (2/191) | 8 (16/213) | 9 (19/213) | 1 (3/213) |
>15 | 19 (69/368) | 8 (29/368) | 3 (11/368) | 26 (92/357) | 19 (67/357) | 8 (27/357) |
All agesa | 11 (78/744) | 7 (50/744) | 2 (14/744) | 15 (109/735) | 13 (95/735) | 4 (30/735) |
SCR (λ) | λ1: 0.004 (0.002–0.007) | 0.014 (0.006–0.032) | λ1: 0.000 (0.000–0.000) | 0.013 (0.008–0.021) | ||
(95 % CI) | λ2: 0.154 (0.020–1.186) | λ2: 0.012 (0.007–0.019) | ||||